Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-11-25
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, A61K 3144
Patent
active
056913605
ABSTRACT:
Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
REFERENCES:
patent: 4550022 (1985-10-01), Garabedian et al.
Peruche, et al., "Mechanisms Of Drug Actions Against Neuronal Damage Caused By Ischemia--An Overview", Prog. Neuro-Psychopharmacol. and Biol. Psychiat., vol. 17, pp. 21-70 (1993).
Miller, R., "Multiple Calcium Channels and Neuronal Function", Science, vol. 235, pp. 46-52 (1987).
Triggle, et al., "Ca.sup.+ Channel Ligands: Structure-Function Relationships of The 1,4-Dihydropyridines", Medicinal Research Reviews, vol. 9, No. 2, pp. 123-180 (1989).
Sahly, et al., "Calcium channel blockers inhibit retinal degeneration in the retinal-degeneration-B mutant of Drosophila", Proc. Natl. Acad. Sci. USA, vol. 89, pp. 435-439 (1992).
Beck, et al., "Local cerebral glucose utilization and local cerebral blood flow in conscious rats after administration of flunarizine", Naunyn-Schmiedeberg's Arch Pharmacol, vol. 335, pp. 680-685 (1987).
Aruoma, et al., "Free Radical Scavenging And Inhibition Of Lipid Peroxidation By .beta.-Blockers And By Agents That Interfere With Calcium Metabolism", Biochemical Pharmacology, vol. 42(4), pp. 735-743 (1991).
Orrenius, et al., "Calcium Ions and Oxidative Cell Injury", Annals of Neurology, supplement to vol. 32, pp. .xi.33-42 (1992).
Jackson, et al., "Antioxidants: A Biological Defense Mechanism for the Prevention of Atherosclerosis", Medicinal Research Reviews, vol. 13, No. 2, pp. 161-182 (1993).
Li, et al., "Amelioration of Retinal Photic Injury by a Combination of Flunarizine and Dimethylthiourea", Experimental Eye Research, vol. 56, pp. 71-78 (1993).
Kubo, et al., "Radical Scavenging Action of Flunarizine in Rat Brain in vitro", Arch. int. Pharmacodyn., vol. 272, pp. 283-295 (1984).
Mak, et al., "Comparative Antioxidant Activities of Propranolol, Nifedipine, Verapamil, and Diltiazem Against Sarcolemmal Membrane Lipid Peroxidation", Circulation Research, vol. 66, No. 5, pp. 1449-1452 (1990).
Breugnot, C., et al., "Calcium Antagonists Prevent Monocyte And Endothelial Cell-Induced Modification Of Low Density Lipoproteins", Free Rad. Res. Comms., vol. 15, No. 2, pp. 91-100 (1991).
Zimmerman, J., et al., "In Vitro Modulation Of Human Neutrophil Superoxide Anion Generation By Various Calcium Channel Antagonists Used In Ischemia-Reperfusion Resuscitation", Biochemical Pharacology, vol. 38, No. 20, pp. 3601-3610 (1989). Calcium Channel Antagonists In The Heart, Cerebral Cortex, And Ileum Of Rats", Life Science, vol. 30, pp. 2191-2202 (1982).
Lamba, O., et al., "Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system", Biochimieu et Biophysica Acta., 1081, pp. 181-187 (1991). discriminate inorganic calcium agonists and antagonists", Proc. Natl. Acad. Sci. USA, vol. 79, pp. 3656-3660 (1982).
Scheschonka, A, et al., "Temporal Relationships Between The Loss Of Vitamin E, Protein Sulfhydryls And Lipid Peroxidation In Microsomes Challenged With Different Prooxidants", Chem.-Biol. Interactions, vol. 74, pp. 233-252 (1990).
Shanklin Jr., J., et al., "Synthesis, Calcium-Channel-Blocking Activity, and Antihypertensive Activity of Compounds", Journal of Medicinal Chemistry, vol. 34, No. 10, pp. 3011-3022 (1991).
Barrett, R., et al., "AHR-16303B, a Novel Antagonist of 5-HT.sub.2 Receptors and Voltage-Sensitive Calcium Channels", Journal of Cardiovascular Pharmacology, vol. 17, No. 1, pp. 41-53 (1991).
Cross et al., Annals of Internal Medicine, 1987, 107: 526-545.
Diplock et al., Annals of The New York Academy of Science, vol. 570, pp. 4-5 (1989).
Oyanagui, Y., "Antioxidant and O.sub.2 -production inhibitory effects of calcium-antagonists", Chemical Abstracts, vol. 117:40025c, No. 5, p. 45, col. 2 (1992).
Barnes George
Collier, Jr. Robert J.
Hellberg Mark R.
Alcon Laboratories Inc.
Arno James A.
Brown Gregg C.
Fan Jane
LandOfFree
Compounds having both potent calcium antagonist and antioxidant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having both potent calcium antagonist and antioxidant , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having both potent calcium antagonist and antioxidant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107427